Zodiac Vent. (503641)
Score breakdown: P/E: 3/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 1/1
Key Financials
| Current Price | ₹14.89 |
| Market Cap | ₹57.74 Cr |
| P/E Ratio | 10.86 |
| ROCE | 8.88% |
| ROE | 7.54% |
| Dividend Yield | 6.45% |
| Profit Growth | 45.45% |
| Debt/Equity | — |
| Sales Growth | 73.24% |
| 52-Week Range | ₹1.18 — ₹14.89 |
| Sector | Commercial Services & Supplies |
| Book Value | ₹1.72 |
AI Analysis
AI-generated, general educational analysis — not personal investment advice.
When I look at Zodiac Vent., I first ask what I am really buying. The headline P/E of 10.86 and a PEG of 0.18 appear attractive if the 73.24% sales growth and 45.45% profit growth are durable. But Benjamin Graham warned that numbers without quality are a trap. The stock has moved from ₹1.18 to ₹14.89—a twelve-fold rise—and the latest quarter shows sales of just ₹1 Cr and net profit of ₹0 Cr. That is not a compounder; that is a very small consulting-services business. Book value is only ₹1.72, yet I am paying ₹14.89, or 8.66 times book. In exchange, the business earns only 7.54% ROE and 8.88% ROCE. That is poor capital productivity for such a high premium. A 6.45% dividend yield sounds good, but with minuscule earnings, dividends may not be sustainable at this level. The Piotroski F-Score of 7 is a positive signal, and the growth rates are impressive, but growth from a tiny base can be misleading. There is no durable moat in consulting services; clients come and go. I look for consistency: this is one quarter, one snapshot. The debt/equity is unavailable, promoter holding unavailable—too many gaps for a prudent investor. Graham would want a margin of safety; at ₹14.89, after a massive re-rating, I do not see one. This is a fast grower on paper, but not a proven business. I would watch it, not own it. If quarterly profits become real and consistent, if ROE moves above 15%, and if the balance sheet stays clean, then the story becomes interesting. Until then, price is betting on momentum, and I do not bet.
The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer